The Clorox (CLX) earnings history
Most recent quarter
- Fiscal period
- Q4 2026
- Period end
- Jun 30, 2026
- EPS actual
- $1.66
- EPS estimate
- $1.64
- EPS surprise
- +1.18%
- Revenue surprise
- +1.73%
- Revenue
- $1.9B
- Revenue estimate
- $1.9B
- Reported
- Aug 3, 2026
Clorox reported fiscal Q4 2026 results on August 3, 2026. Earnings per share came in at $1.66, ahead of the $1.64 estimate by 1.18%. Revenue was $1.9 billion, 1.73% above the consensus. Compared with Q4 2025, EPS fell about 42% from $2.87, and revenue slipped about 5% from $2.0 billion.
That quarter closed a weaker fiscal year. Annual EPS rose from $4.11 in fiscal 2022 to $5.09 in 2023, $6.18 in 2024 and $7.73 in 2025, then fell about 28% to $5.54 in fiscal 2026. Within fiscal 2026, EPS climbed each quarter, from $0.85 in Q1 to $1.66 in Q4. Q4 2025 holds the EPS high in the table, at $2.87. The lowest EPS was $0.49, in Q1 2024. Over the last 20 quarters, Clorox topped the EPS estimate 17 times. The largest beat came in Q1 2024, when EPS of $0.49 compared with an estimated loss of $0.24.
Clorox reported fiscal Q1 between October 30 and November 3 in each of the past five years. That points to late October or early November 2026 for the next report. It will open fiscal 2027 and can be compared with the $0.85 earned in Q1 2026.
Earnings history
| Period | Reported | EPS estimate | EPS actual | Surprise | Revenue | Filing |
|---|---|---|---|---|---|---|
| Q4 2026 | Aug 3, 2026 | $1.64 | $1.66 | +1.18% | $1.9B | SEC |
| Q3 2026 | Apr 30, 2026 | $1.55 | $1.64 | +6.03% | $1.7B | SEC |
| Q2 2026 | Feb 3, 2026 | $1.43 | $1.39 | −3.01% | $1.7B | SEC |
| Q1 2026 | Nov 3, 2025 | $0.78 | $0.85 | +9.23% | $1.4B | SEC |
| Q4 2025 | Jul 31, 2025 | $2.20 | $2.87 | +30.26% | $2.0B | SEC |
| Q3 2025 | May 5, 2025 | $1.55 | $1.45 | −6.53% | $1.7B | SEC |
| Q2 2025 | Feb 3, 2025 | $1.40 | $1.55 | +10.82% | $1.7B | SEC |
| Q1 2025 | Oct 30, 2024 | $1.41 | $1.86 | +31.65% | $1.8B | SEC |
| Q4 2024 | Aug 1, 2024 | $1.55 | $1.82 | +17.09% | $1.9B | SEC |
| Q3 2024 | Apr 30, 2024 | $1.36 | $1.71 | +25.60% | $1.8B | SEC |
| Q2 2024 | Feb 1, 2024 | $1.09 | $2.16 | +97.68% | $2.0B | SEC |
| Q1 2024 | Nov 1, 2023 | −$0.24 | $0.49 | +301.98% | $1.4B | SEC |
| Q4 2023 | Aug 2, 2023 | $1.17 | $1.67 | +43.04% | $2.0B | SEC |
| Q3 2023 | May 2, 2023 | $1.23 | $1.51 | +23.12% | $1.9B | SEC |
| Q2 2023 | Feb 2, 2023 | $0.66 | $0.98 | +48.73% | $1.7B | SEC |
| Q1 2023 | Nov 1, 2022 | $0.74 | $0.93 | +25.10% | $1.7B | SEC |
| Q4 2022 | Aug 3, 2022 | $0.93 | $0.93 | +0.29% | $1.8B | SEC |
| Q3 2022 | May 2, 2022 | $0.92 | $1.31 | +41.94% | $1.8B | SEC |
| Q2 2022 | Feb 3, 2022 | $0.80 | $0.66 | −16.98% | $1.7B | SEC |
| Q1 2022 | Nov 1, 2021 | $1.03 | $1.21 | +17.28% | $1.8B | — |
Quarterly revenue
Frequently asked questions
When did The Clorox (CLX) last report earnings?
The Clorox last reported on Aug 3, 2026, covering fiscal Q4 2026.
Did CLX beat earnings estimates?
Yes. The Clorox reported EPS of $1.66 for Q4 2026 against a $1.64 estimate — a 1.18% beat.
How much revenue did CLX report last quarter?
The Clorox reported $1.9B in revenue for Q4 2026, against a consensus estimate of $1.9B.
Earnings figures may be restated, revised or corrected by the issuer. Past results do not indicate future performance.
This page is for informational purposes only. Nothing on it is a recommendation, solicitation or offer to buy or sell any security, nor investment, legal or tax advice. Light Horse Securities Inc does not verify third-party data and is not responsible for its accuracy, completeness or timeliness.